Brandan Kramer, MD
Urology · North Kansas City, MONPI 1639391055
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,500 of the $33,931 with a category attached, or 75.2%. Boston Scientific accounts for 81.8% of it on its own, with 47 other manufacturers making up the rest. Reporting peaked in 2022 at $12,925 and has fallen 90.6% since, to $1,215 in 2025. Among urology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $101.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$28K
- Astellas Pharma US Inc$843
- AbbVie$546
- Antares Pharma, Inc.$538
- Johnson & Johnson$537
- Procept Biorobotics Corporation$410
- plus $3K from 42 others
What the payments were for
- Consulting fees$25,50075%
- Speaking & faculty fees$3751%
- Travel & lodging$1,0003%
- Food & beverage$6,78320%
- Education$2731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Piranha$8,000
- LithoVue$5,304
- 8/10 Dilator/Sheath Set$4,000
- CLEAR RENAL SHEATH$2,000
- GENERAL KIDNEY STONE DISEASE$1,679
- AMS$500
- AquaBeam Robotic System$410
- REZUM$375
- PTS250$309
- GENERAL - THERAPIES$223
- Erleada$111
How this compares
$33,931 in reported general payments places this provider in the 90th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 93 | $105,293 |
| MyrbetriqMirabegron | 50 | $40,967 |
| Tamsulosin Hcl | 782 | $12,786 |
| Finasteride | 410 | $6,223 |
| Potassium Citrate ErPotassium Citrate | 29 | $3,264 |
| Solifenacin Succinate | 94 | $2,911 |
| Dutasteride | 54 | $1,996 |
| NitrofurantoinNitrofurantoin Macrocrystal | 67 | $1,757 |
| Oxybutynin Chloride ErOxybutynin Chloride | 48 | $1,687 |
| Silodosin | 15 | $1,530 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 45 | $1,219 |
| Indapamide | 84 | $679 |
| Testosterone Cypionate | 23 | $600 |
| Methenamine Hippurate | 11 | $547 |
| Megestrol Acetate | 14 | $410 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $114 | $105,29393 claims |
| Astellas Pharma US IncMyrbetriq | $843 | $40,96750 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 250 urology providers in Missouri.
Other urology in North Kansas City
- Gerald ParkNorth Kansas City$136K
- Keegan ZukNorth Kansas City$8K
- Travis BullockSaint Louis$201K
- Michael JohnsonSaint Louis$160K
- Samuel KuykendallKansas City$141K
- Gurdarshan SandhuSaint Louis$101K
- Etai GoldenbergSt. Louis$95K
- Gregory McLennanSaint Louis$89K
- Majdee IslamSaint Peters$64K
- Gerald AndrioleSaint Louis$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.